Dennis Calvert, CEO of BioLargo Inc., Returns to Uptick Newswire's "Stock Day" Podcast
Mar 09, 2018 13:01 pm UTC| Business
Westminster, March 09, 2018 -- Westminster, CA – March 9, 2018 – BioLargo, Inc. (OTCQB: BLGO) (“BioLargo” the “Company”), an innovator of sustainable science, technology and full-service environmental engineering...
CDTi Announces Name Change to CDTi Advanced Materials, Inc.
Mar 09, 2018 13:01 pm UTC| Business
OXNARD, Calif., March 09, 2018 -- Clean Diesel Technologies, Inc. (Nasdaq:CDTI) (“CDTi” or “the Company”), a leader in advanced emission control technology, announced it has changed its corporate name to CDTi Advanced...
DropCar Announces $6,000,000 Private Placement
Mar 09, 2018 13:01 pm UTC| Business
Financing Will Support Expansion of Consumer and Enterprise BusinessesReinforced Balance Sheet Should Augment DropCar’s Ability to Secure New Large OEM Deals NEW YORK, March 09, 2018 -- DropCar, Inc. (NASDAQ:DCAR), a...
Exalenz Bioscience to Participate in Upcoming Investor Conferences
Mar 09, 2018 13:01 pm UTC| Business
MODI’IN, Israel and MANASQUAN, N.J., March 09, 2018 -- Exalenz Bioscience Ltd. (TASE:EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and...
Vericel to Present at BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference
Mar 09, 2018 13:01 pm UTC| Business
CAMBRIDGE, Mass., March 09, 2018 -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Gerard Michel, chief financial...
Mar 09, 2018 13:01 pm UTC| Business
NEW YORK, March 09, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Envision...
Mar 09, 2018 13:01 pm UTC| Business
Issuance of U.S. Patent No. 9,895,301 Further Bolsters Aclaris’ Intellectual Patent Portfolio WAYNE, Pa., March 09, 2018 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company...